Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001013762-24-001270
Filing Date
2024-07-26
Accepted
2024-07-26 06:04:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A ea021006101-defa14a_allar.htm DEFA14A 12691
2 GRAPHIC image_001.jpg GRAPHIC 10137
  Complete submission text file 0001013762-24-001270.txt   27793
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41160 | Film No.: 241143473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)